BBI Solutions Showcases Mobile Solutions Capabilities at AACC 2019
By LabMedica International staff writers Posted on 06 Aug 2019 |
Image: The Novarum mobile app enables rapid POCT using just a smartphone (Photo courtesy of BBI Solutions).
BBI Solutions (Crumlin, UK) demonstrated how its lateral flow software is making point-of-care testing (POCT) more accurate, efficient and easier to use than ever before at the world’s largest laboratory medicine trade show, American Association for Clinical Chemistry (AACC) exhibition.
BBI Solutions are leading experts in immunoassay development & manufacturing services, offering an extensive portfolio of diagnostic products globally. At the AACC Clinical Lab Expo, BBI’s mobile arm, Novarum, launched a demonstrator app that can read the results of an imitated malaria test. Novarum is an easy-to-use mobile app enabling rapid POCT, using just a smartphone. Novarum’s technology accurately interprets the results of lateral flow assays while offering test choreography and tracking disease outbreaks, providing clients with a competitive advantage within the diagnostic landscape. At the tradeshow, the company demonstrated how mobile technology can remove complexities from lateral flow testing to enable healthcare professionals or patients to deliver lab quality results in the field.
Novarum’s innovative mobile technology mitigates the risks identified around lateral flow by the Clinical Laboratory Improvement Amendments (CLIA), which establishes quality standards for all laboratory testing to ensure the accuracy, reliability and timeliness of patient test results. The company demonstrated every aspect of its immunoassay development - feasibility and planning, reagent supply and manufacturing, custom antibody development, custom conjugations, lateral flow development and manufacturing, as well as Novarum’s smartphone reader capability which enables immediate, POC diagnosis.
“This is an exciting opportunity to, once again, showcase BBI Solutions’ comprehensive suite of capabilities at the AACC expo. We’re particularly excited to be launching our demo app at the event this year, which enables us to demonstrate every aspect of Novarum’s capability that a potential customer could include in a custom-built app,” said John Hanson, Chief Commercial Officer at BBI Solutions. “We want to help our customers envision what it would be like for the healthcare professional or patient using the test and to highlight how Novarum’s software mitigates the risks identified around lateral flow testing.”
BBI Solutions are leading experts in immunoassay development & manufacturing services, offering an extensive portfolio of diagnostic products globally. At the AACC Clinical Lab Expo, BBI’s mobile arm, Novarum, launched a demonstrator app that can read the results of an imitated malaria test. Novarum is an easy-to-use mobile app enabling rapid POCT, using just a smartphone. Novarum’s technology accurately interprets the results of lateral flow assays while offering test choreography and tracking disease outbreaks, providing clients with a competitive advantage within the diagnostic landscape. At the tradeshow, the company demonstrated how mobile technology can remove complexities from lateral flow testing to enable healthcare professionals or patients to deliver lab quality results in the field.
Novarum’s innovative mobile technology mitigates the risks identified around lateral flow by the Clinical Laboratory Improvement Amendments (CLIA), which establishes quality standards for all laboratory testing to ensure the accuracy, reliability and timeliness of patient test results. The company demonstrated every aspect of its immunoassay development - feasibility and planning, reagent supply and manufacturing, custom antibody development, custom conjugations, lateral flow development and manufacturing, as well as Novarum’s smartphone reader capability which enables immediate, POC diagnosis.
“This is an exciting opportunity to, once again, showcase BBI Solutions’ comprehensive suite of capabilities at the AACC expo. We’re particularly excited to be launching our demo app at the event this year, which enables us to demonstrate every aspect of Novarum’s capability that a potential customer could include in a custom-built app,” said John Hanson, Chief Commercial Officer at BBI Solutions. “We want to help our customers envision what it would be like for the healthcare professional or patient using the test and to highlight how Novarum’s software mitigates the risks identified around lateral flow testing.”
Latest AACC 2019 News
- Instrumentation Laboratory Presents New IVD Testing System
- Quidel Welcomes Newest Member of Triage Family
- ERBA Mannheim Unveils Next-Generation Automation
- Roche Demonstrates How Health Networks Are Driving Change in Labs and Beyond
- BioMérieux Spotlights Diagnostic Solutions in Use of Antibiotics
- Thermo Shows New Clinical Innovations
- Randox Launches New Innovations
- Streck Introduces Three New Antibiotic Resistance Detection Kits
- EKF Diagnostics Highlights Assay for Diabetes Patient Monitoring
- Sysmex America Exhibits New Products, Automation and Quality Solutions
- MedTest Dx Releases New Product Line for Drugs of Abuse Testing
- Mesa Biotech Launches Molecular Test System at AACC 2019
- Ortho Clinical Diagnostics Highlights Groundbreaking Lab Technology
- Abbott Diagnostics Exhibits POC Diagnostics Solutions at AACC
- Beckman Coulter Demonstrates Latest Innovations in Lab Medicine
- Orion Diagnostica Showcases Range of Products in Anaheim